BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10768157)

  • 1. [Clinical analysis of the effectiveness and safety of vigabatrin].
    Jedrzejczak J; Owczarek K
    Neurol Neurochir Pol; 2000; 34 Suppl 1():177-85. PubMed ID: 10768157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. The Canadian Vigabatrin Study Group.
    Bruni J; Guberman A; Vachon L; Desforges C
    Seizure; 2000 Apr; 9(3):224-32. PubMed ID: 10777431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vigabatrin in the treatment of intractable focal epilepsy in children and adolescents. Two-year study].
    Kozik A; Ujma-Czapska B; Grotowska M
    Neurol Neurochir Pol; 2000; 34 Suppl 1():187-93. PubMed ID: 10768158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vigabatrin in pediatric patients with refractory epilepsy.
    Turanli G; Celebi A; Yalnizoğlu D; Topçu M; Topaloğlu H; Banu A; Aysun S
    Turk J Pediatr; 2006; 48(1):25-30. PubMed ID: 16562782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lamotrigine versus vigabatrin as an add-on therapy in refractory epilepsy: prospective study].
    Maciejek Z; Niezgodzińska-Maciejek A
    Neurol Neurochir Pol; 2000; 34 Suppl 1():165-75. PubMed ID: 10768156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response study of vigabatrin in children with refractory epilepsy.
    Herranz JL; Arteaga R; Farr IN; Valdizan E; Beaumont D; Armijo JA
    J Child Neurol; 1991; Suppl 2():S45-51. PubMed ID: 1940124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vigabatrin in childhood seizure disorders: results from a clinical audit.
    Prasad AN; Penney S; Buckley DJ
    Epilepsia; 2001 Jan; 42(1):54-61. PubMed ID: 11207785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
    Camposano SE; Major P; Halpern E; Thiele EA
    Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABI-balance--a non-interventional observational study on the effectiveness of tiagabine in add-on therapy in partial epilepsy.
    Chmielewska B; Stelmasiak Z
    Neurol Neurochir Pol; 2008; 42(4):303-11. PubMed ID: 18975234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex.
    Friedman D; Bogner M; Parker-Menzer K; Devinsky O
    Epilepsy Behav; 2013 Apr; 27(1):118-20. PubMed ID: 23399947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre clinical evaluation of vigabatrin (Sabril) in mild to moderate partial epilepsies. French Neurologists Sabril Study Group.
    Arzimanoglou AA; Dumas C; Ghirardi L
    Seizure; 1997 Jun; 6(3):225-31. PubMed ID: 9203252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].
    Vogt H; Krämer G
    Schweiz Med Wochenschr; 1995 Jan; 125(4):125-32. PubMed ID: 7878401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy.
    Kluger G; Berz K; Holthausen H
    Eur J Paediatr Neurol; 2001; 5(1):37-40. PubMed ID: 11277363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term follow-up of childhood epilepsy treated with vigabatrin outside of clinical trials].
    Garaizar C; Martínez-González MJ; Fernández-Cuesta MA; Prats JM
    Rev Neurol; 1999 Aug 1-15; 29(3):201-7. PubMed ID: 10797902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of vigabatrin vs. carbamazepine in monotherapy of newly diagnosed partial seizures in children.
    Sobaniec W; Kułak W; Strzelecka J; Smigielska-Kuzia J; Boćkowski L
    Pharmacol Rep; 2005; 57(5):646-53. PubMed ID: 16227648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term open multicentre, add-on trial of vigabatrin in adult resistant partial epilepsy. The Canadian Vigabatrin Study Group.
    Guberman A; Bruni J
    Seizure; 2000 Mar; 9(2):112-8. PubMed ID: 10845734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigabatrin in low doses selectively suppresses the clonic component of audiogenically kindled seizures in rats.
    Vinogradova LV; Kuznetsova GD; Shatskova AB; van Rijn CM
    Epilepsia; 2005 Jun; 46(6):800-10. PubMed ID: 15946321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vigabatrin therapy in infantile spasms.
    Kankirawatana P; Raksadawan N; Balangkura K
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S778-83. PubMed ID: 12403260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.